You have 9 free searches left this month | for more free features.

surgery for carcinoid tumor

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Small Bowel Cancer, Small Bowel Carcinoid Tumor, Quality of Life Trial in Lorenskog (Surgery with extended (D3) mesenterectomy

Recruiting
  • Small Bowel Cancer
  • +4 more
  • Surgery with extended (D3) mesenterectomy for small bowel tumors
  • Lorenskog, Norway
    Akershus University Hospital
Jan 3, 2023

68Ga-DOTATOC Radio-Guided Surgery With ß-Probe in GEP-NET

Recruiting
  • Neuroendocrine Tumor Carcinoid
  • +2 more
    • Milan, Italy
      IRCCS Istituto Europeo di Oncologia S.r.l.
    Jul 8, 2022

    Midgut Carcinoid Tumor, Biliary Stones Trial in Spain (Primary tumor surgery, Primary tumor surgery (bowel resection) combined

    Recruiting
    • Midgut Carcinoid Tumor
    • Biliary Stones
    • Primary tumor surgery
    • Primary tumor surgery (bowel resection) combined with prophylactic cholecystectomy
    • Badalona, Barcelona, Spain
    • +5 more
    Jul 6, 2022

    Metastatic Cancer, Foregut Carcinoid Tumor, Gastric Adenocarcinoma Trial (drug, procedure, radiation, other)

    Not yet recruiting
    • Metastatic Cancer
    • +7 more
    • Standard of Care Chemotherapy
    • +7 more
    • (no location specified)
    Apr 1, 2022

    Lung Carcinoid Tumor, Lung Non-Small Cell Carcinoma, Metastatic Lung Carcinoma Trial in Houston (Cone-Beam Computed Tomography,

    Completed
    • Lung Carcinoid Tumor
    • +5 more
    • Cone-Beam Computed Tomography
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 14, 2022

    Caregiver, Lobectomy Patient, Lung Carcinoid Tumor Trial (E-mail, Exercise Intervention, Quality-of-Life Assessment)

    Withdrawn
    • Caregiver
    • +3 more
    • E-mail
    • +5 more
    • (no location specified)
    Aug 10, 2021

    Carcinoid Syndrome, Carcinoid, Carcinoid Tumor Trial in Newport Beach, Lexington, Stony Brook (Randomized: 40 mg Paltusotine,

    Recruiting
    • Carcinoid Syndrome
    • +8 more
    • Randomized: 40 mg Paltusotine
    • Randomized: 80 mg Paltusotine
    • Newport Beach, California
    • +5 more
    Jan 3, 2023

    Carcinoid Tumor Trial in Boston (Ziv-aflibercept)

    Active, not recruiting
    • Carcinoid Tumor
    • Boston, Massachusetts
    • +2 more
    Oct 14, 2022

    Advanced Carcinoid Tumor, Digestive System Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1 Trial in Houston

    Recruiting
    • Advanced Carcinoid Tumor
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 22, 2022

    Carcinoid Tumor, Pancreatic Neuroendocrine Tumor Trial in Boston (Cabozantinib)

    Active, not recruiting
    • Carcinoid Tumor
    • Pancreatic Neuroendocrine Tumor
    • Boston, Massachusetts
    • +1 more
    Jul 15, 2022

    Neuroendocrine Tumors, Carcinoid Tumor of GI System, Diarrhea Trial in Lexington (Amino Acid Based Medical Food/Drink)

    Completed
    • Neuroendocrine Tumors
    • +3 more
    • Amino Acid Based Medical Food/Drink
    • Lexington, Kentucky
      University of Kentucky Markey Cancer Center
    Nov 2, 2022

    Neuroendocrine Tumors Trial (Telotristat Ethyl Oral Tablet)

    Withdrawn
    • Neuroendocrine Tumors
    • Telotristat Ethyl Oral Tablet
    • (no location specified)
    Dec 3, 2021

    Tricuspid Regurgitation, Tricuspid Valve Disease, Carcinoid Syndrome Trial in London (Transcatheter Tricuspid Valved Stent

    Not yet recruiting
    • Tricuspid Regurgitation
    • +3 more
    • Transcatheter Tricuspid Valved Stent Graft
    • London, England, United Kingdom
      Barts Health NHS Trust
    Apr 19, 2022

    Locally Advanced Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in Houston (Placebo Administration, Questionnaire

    Recruiting
    • Locally Advanced Neuroendocrine Neoplasm
    • Metastatic Neuroendocrine Neoplasm
    • Placebo Administration
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 31, 2023

    Carcinoid Tumor, Metastatic Carcinoid Tumor, Neuroendocrine Tumor Trial in Buffalo, Columbus (Laboratory Biomarker Analysis,

    Active, not recruiting
    • Carcinoid Tumor
    • +2 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Buffalo, New York
    • +1 more
    Nov 8, 2022

    Carcinoid Tumor Lung, Neuroendocrine Tumor of the Lung, Carcinoma, Small-Cell Lung Trial in Iowa City (212-Lead Pentixather,

    Not yet recruiting
    • Carcinoid Tumor Lung
    • +2 more
    • 212-Lead Pentixather
    • 203-Lead Pentixather SPECT/CT
    • Iowa City, Iowa
      The University of Iowa Theranostics Center
    Sep 23, 2022

    Advanced Lung Carcinoid Tumor, Functioning Lung Carcinoid Tumor, Locally Advanced Lung Neuroendocrine Tumor Trial in Boston,

    Recruiting
    • Advanced Lung Carcinoid Tumor
    • +11 more
    • Boston, Massachusetts
    • +1 more
    Jul 19, 2022

    Carcinoid Tumors Trial in Boston (Ramucirumab, Somatostatin Analog)

    Active, not recruiting
    • Carcinoid Tumors
    • Boston, Massachusetts
    • +1 more
    Apr 14, 2022

    Neuroendocrine Tumors, Carcinoid Syndrome, Diarrhea Trial in Iowa City (Telotristat ethyl, Peptide Receptor Radionuclide

    Withdrawn
    • Neuroendocrine Tumors
    • +2 more
    • Telotristat ethyl
    • +2 more
    • Iowa City, Iowa
      University of Iowa Hospital and Clinics
    Feb 9, 2022

    Neuroendocrine Tumors, Carcinoid Tumor, Pulmonary Carcinoid Tumor Trial in Vancouver (177Lu-DOTATOC)

    Not yet recruiting
    • Neuroendocrine Tumors
    • +6 more
    • Vancouver, British Columbia, Canada
      BC Cancer
    Aug 19, 2022

    Genetics of Appendix Cancer Study

    Recruiting
    • Appendix Cancer
    • +14 more
    • Genetic profiling
    • Retrospective tissue procurement
    • Nashville, Tennessee
      Vanderbilt-Ingram Cancer Center
    Feb 8, 2023

    Advanced Neuroendocrine Tumor, Carcinoid Syndrome Trial (Retifanlimab, Telotristat Ethyl)

    Withdrawn
    • Advanced Neuroendocrine Neoplasm
    • Carcinoid Syndrome
    • Retifanlimab
    • Telotristat Ethyl
    • (no location specified)
    Sep 23, 2021

    Carcinoid Syndrome, Carcinoid Tumor, Digestive System Neuroendocrine Tumor G1 Trial in Houston (Dual-Energy Computed Tomography)

    Recruiting
    • Carcinoid Syndrome
    • +3 more
    • Dual-Energy Computed Tomography
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 28, 2021